tiprankstipranks
Helix BioPharma (TSE:HBP)
TSX:HBP
Canadian Market
Holding TSE:HBP?
Track your performance easily

Helix BioPharma (HBP) Financial Statements

25 Followers

Helix BioPharma Financial Overview

Helix BioPharma's market cap is currently ―. The company's EPS TTM is C$-0.203; its P/E ratio is -3.43; Helix BioPharma is scheduled to report earnings on December 11, 2024, and the estimated EPS forecast is C$―. See an overview of income statement, balance sheet, and cash flow financials.
Jul 24Apr 24Jan 24Oct 23Jul 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT-C$ -1.83MC$ -880.00KC$ -1.25MC$ -2.15M
EBITDA-C$ -1.82MC$ -877.00KC$ -1.25MC$ -2.15M
Net Income Common Stockholders-C$ -1.83MC$ -902.00KC$ -1.25MC$ -2.15M
Balance Sheet-
Cash, Cash Equivalents and Short-Term InvestmentsC$ 1.08MC$ 710.00KC$ 120.00KC$ 1.64MC$ 808.00K
Total AssetsC$ 1.49MC$ 1.15MC$ 343.00KC$ 1.90MC$ 1.03M
Total DebtC$ 0.00C$ 0.00C$ 0.00C$ 0.00C$ 0.00
Net DebtC$ -1.08MC$ -710.00KC$ -120.00KC$ -1.64MC$ -808.00K
Total LiabilitiesC$ 1.58MC$ 1.50MC$ 603.00KC$ 1.27MC$ 1.87M
Stockholders EquityC$ -90.00KC$ -851.00KC$ -259.00KC$ 622.00KC$ -845.00K
Cash Flow-
Free Cash Flow-----
Operating Cash FlowC$ -747.00KC$ -1.13MC$ -1.49MC$ -1.85MC$ -1.54M
Investing Cash FlowC$ -2.00K--C$ -12.00KC$ 4.00K
Financing Cash FlowC$ 1.10MC$ 1.72MC$ 1.00KC$ 2.69MC$ 998.00K
Currency in CAD

Helix BioPharma Earnings and Revenue History

Helix BioPharma Debt to Assets

Helix BioPharma Cash Flow

Helix BioPharma Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis